Geron (GERN) Other Gross PP&E Adjustments (2011 - 2026)
Geron recorded quarterly Other Gross PP&E Adjustments of -$2.0 million in Q1 2026, up 80.65% quarter-over-quarter from -$10.1 million in Q4 2025, and up 27.55% year-over-year from -$1.5 million in Q1 2025.
Geron's Other Gross PP&E Adjustments history runs 16 years deep, the most recent figure standing at -$2.0 million for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments rose 27.55% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$2.0 million (up 27.55% YoY), while the FY2025 annual figure was -$10.1 million, down 23.08% from the prior year.
- Other Gross PP&E Adjustments came in at -$2.0 million for Q1 2026 at Geron, up from -$10.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$1.7 million in Q4 2023 to a low of -$12.1 million in Q4 2022.
- A 5-year average of -$5.5 million and a median of -$4.5 million in 2024 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments soared 85.95% in 2023 and tumbled 382.81% in 2024, its largest moves.
- Geron's Other Gross PP&E Adjustments stood at -$12.1 million in 2022, then jumped by 85.95% to -$1.7 million in 2023, then slumped by 382.81% to -$8.2 million in 2024, then declined by 23.08% to -$10.1 million in 2025, then jumped by 80.65% to -$2.0 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$2.0 million, -$10.1 million, and -$2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Geron | 856,799.98 | 856,799.98 | - | -1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.96 Mn |
| Mar 31, 2026 | -1.96 Mn |
| Dec 31, 2025 | -10.13 Mn |
| Dec 31, 2025 | -10.13 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Jun 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -2.52 Mn |
| Mar 31, 2025 | -2.70 Mn |
| Mar 31, 2025 | -2.70 Mn |
| Dec 31, 2024 | -8.23 Mn |
| Dec 31, 2024 | -8.23 Mn |
| Sep 30, 2024 | -3.81 Mn |
| Sep 30, 2024 | -3.81 Mn |
| Jun 30, 2024 | -4.32 Mn |
| Jun 30, 2024 | -4.32 Mn |
| Mar 31, 2024 | -4.45 Mn |
| Mar 31, 2024 | -4.45 Mn |
| Dec 31, 2023 | -1.70 Mn |
| Dec 31, 2023 | -1.70 Mn |
| Sep 30, 2023 | -4.40 Mn |
| Sep 30, 2023 | -4.40 Mn |
| Jun 30, 2023 | -4.70 Mn |
| Jun 30, 2023 | -4.70 Mn |
| Mar 31, 2023 | -4.89 Mn |
| Mar 31, 2023 | -4.89 Mn |
| Dec 31, 2022 | -12.13 Mn |
| Dec 31, 2022 | -12.13 Mn |
| Sep 30, 2022 | -7.70 Mn |
| Sep 30, 2022 | -7.70 Mn |
| Jun 30, 2022 | -7.04 Mn |
| Jun 30, 2022 | -7.04 Mn |
| Mar 31, 2022 | -10.02 Mn |
| Mar 31, 2022 | -10.02 Mn |
| Dec 31, 2021 | -5.46 Mn |
| Dec 31, 2021 | -5.46 Mn |
| Sep 30, 2021 | -4.89 Mn |
| Sep 30, 2021 | -4.89 Mn |
| Jun 30, 2021 | -5.03 Mn |
| Jun 30, 2021 | -5.03 Mn |
| Mar 31, 2021 | -5.16 Mn |
| Mar 31, 2021 | -5.16 Mn |
| Dec 31, 2020 | -4.66 Mn |
| Dec 31, 2020 | -4.66 Mn |
| Sep 30, 2020 | -5.43 Mn |
| Sep 30, 2020 | -5.43 Mn |
| Jun 30, 2020 | -5.49 Mn |
| Jun 30, 2020 | -5.49 Mn |
| Mar 31, 2020 | -149,000.00 |
| Mar 31, 2020 | -149,000.00 |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Sep 30, 2019 | -349,000.00 |
| Sep 30, 2019 | -349,000.00 |
| Jun 30, 2019 | -402,000.00 |
| Jun 30, 2019 | -402,000.00 |
| Mar 31, 2019 | -571,000.00 |
| Mar 31, 2019 | -571,000.00 |
| Dec 31, 2018 | 511,000.00 |
| Dec 31, 2018 | 511,000.00 |
| Dec 31, 2017 | 550,000.00 |
| Dec 31, 2017 | 550,000.00 |
| Dec 31, 2016 | 1.04 Mn |
| Dec 31, 2016 | 1.04 Mn |
| Dec 31, 2015 | 971,000.00 |
| Dec 31, 2015 | 971,000.00 |
| Dec 31, 2014 | 931,000.00 |
| Dec 31, 2014 | 931,000.00 |
| Dec 31, 2013 | 1.28 Mn |
| Dec 31, 2013 | 1.28 Mn |
| Dec 31, 2012 | 13.45 Mn |
| Dec 31, 2012 | 13.45 Mn |
| Dec 31, 2011 | 18.54 Mn |
| Dec 31, 2011 | 18.54 Mn |